FY2024 Earnings Forecast for INSP Issued By Leerink Partnrs

Inspire Medical Systems, Inc. (NYSE:INSP) – Equities researchers at Leerink Partnrs increased their FY2024 EPS estimates for shares of Inspire Medical Systems in a research report issued on Monday, November 4th. Leerink Partnrs analyst M. Kratky now expects that the company will post earnings of $1.38 per share for the year, up from their previous forecast of $0.79. The consensus estimate for Inspire Medical Systems’ current full-year earnings is $0.75 per share. Leerink Partnrs also issued estimates for Inspire Medical Systems’ Q1 2025 earnings at ($0.25) EPS, Q2 2025 earnings at $0.41 EPS, Q3 2025 earnings at $0.48 EPS, FY2025 earnings at $1.76 EPS, FY2026 earnings at $2.67 EPS and FY2027 earnings at $3.63 EPS.

Several other analysts also recently commented on INSP. Royal Bank of Canada restated an “outperform” rating and set a $260.00 target price on shares of Inspire Medical Systems in a report on Tuesday. Wells Fargo & Company raised their price objective on shares of Inspire Medical Systems from $187.00 to $198.00 and gave the stock an “equal weight” rating in a report on Tuesday. Truist Financial reaffirmed a “buy” rating and issued a $240.00 price objective (up from $217.00) on shares of Inspire Medical Systems in a research report on Monday, September 30th. Morgan Stanley lowered their target price on Inspire Medical Systems from $250.00 to $210.00 and set an “overweight” rating for the company in a report on Monday, July 15th. Finally, Robert W. Baird boosted their price target on Inspire Medical Systems from $240.00 to $252.00 and gave the company an “outperform” rating in a report on Tuesday. Four research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $227.75.

Inspire Medical Systems Price Performance

NYSE:INSP opened at $200.47 on Thursday. The business’s 50-day simple moving average is $201.94 and its 200-day simple moving average is $179.94. Inspire Medical Systems has a fifty-two week low of $123.00 and a fifty-two week high of $257.40. The stock has a market capitalization of $5.98 billion, a PE ratio of 187.43 and a beta of 1.36.

Inspire Medical Systems (NYSE:INSP) last posted its earnings results on Monday, November 4th. The company reported $0.60 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.54. Inspire Medical Systems had a return on equity of 5.51% and a net margin of 4.37%. The firm had revenue of $203.20 million for the quarter, compared to analyst estimates of $197.59 million. During the same period in the previous year, the company posted ($0.29) earnings per share. The company’s revenue for the quarter was up 32.6% on a year-over-year basis.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the business. Bank of New York Mellon Corp boosted its holdings in shares of Inspire Medical Systems by 32.3% during the 2nd quarter. Bank of New York Mellon Corp now owns 787,815 shares of the company’s stock worth $105,433,000 after buying an additional 192,238 shares during the period. William Blair Investment Management LLC boosted its holdings in shares of Inspire Medical Systems by 1.8% during the second quarter. William Blair Investment Management LLC now owns 770,413 shares of the company’s stock worth $103,104,000 after acquiring an additional 13,602 shares during the period. Price T Rowe Associates Inc. MD grew its position in shares of Inspire Medical Systems by 51.8% in the first quarter. Price T Rowe Associates Inc. MD now owns 459,766 shares of the company’s stock valued at $98,754,000 after purchasing an additional 156,893 shares during the last quarter. Allspring Global Investments Holdings LLC increased its stake in shares of Inspire Medical Systems by 798.3% during the third quarter. Allspring Global Investments Holdings LLC now owns 267,852 shares of the company’s stock worth $56,530,000 after purchasing an additional 238,034 shares during the period. Finally, AQR Capital Management LLC lifted its holdings in Inspire Medical Systems by 152.7% during the 2nd quarter. AQR Capital Management LLC now owns 231,845 shares of the company’s stock worth $31,028,000 after purchasing an additional 140,090 shares during the last quarter. 94.91% of the stock is currently owned by institutional investors.

Insider Activity at Inspire Medical Systems

In other news, Director Shawn Mccormick sold 800 shares of the stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $220.00, for a total value of $176,000.00. Following the completion of the sale, the director now owns 23,140 shares of the company’s stock, valued at approximately $5,090,800. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In related news, insider Randy Ban sold 4,861 shares of Inspire Medical Systems stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $188.55, for a total transaction of $916,541.55. Following the completion of the transaction, the insider now owns 3,056 shares in the company, valued at approximately $576,208.80. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Shawn Mccormick sold 800 shares of the business’s stock in a transaction that occurred on Monday, September 9th. The stock was sold at an average price of $220.00, for a total value of $176,000.00. Following the transaction, the director now directly owns 23,140 shares in the company, valued at approximately $5,090,800. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 5,692 shares of company stock valued at $1,099,207. 4.10% of the stock is owned by insiders.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.